Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Items 701–800 of 1,000
Kaski, J. P., & Elliot, P. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-3064-2.00052-7 · Cited by 5
Left ventricular assist device implantation in an adult male with Danon disease
Kuroda, K., Seguchi, O., Matama, H., Kimura, Y., Iwasaki, K., Toda, K., Kikuchi, N., Kumai, Y., Nakajima, S., Matsumoto, Y., et al. (2019) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2019.06.002 · Cited by 5
“This disease is one of the autophagic vacuolar myopathies caused by a primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) and is known as an X-linked dominant disorder [2].”
BackgroundDiseases Associated with Primary Abnormalities in Carbohydrate Metabolism
Patterson, M. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00039-4 · Cited by 5
Spontaneous hypertrophic cardiomyopathy in a cynomolgus macaque (Macaca fascicularis)
Konishi, S., Kotera, T., Koga, M., & Ueda, M. (2017) · Journal of Toxicologic Pathology · doi:10.1293/tox.2017-0027 · Cited by 5
Molecular mechanisms of pediatric cardiomyopathies and new targeted therapies
Towbin, J. A. (2008) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2007.11.001 · Cited by 5
Histopathology and immunoanalysis of muscle
Sewry, C. A., & Molnár, M. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.009 · Cited by 5
Editorial commentary: Highlighting the ray of hope in Danon disease research after 40 years
Sugie, K. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.11.007 · Cited by 5
Macroautophagy in Mammalian Cells
Eskelinen, E.-L. (2007) · Lysosomes · doi:10.1007/0-387-28957-7_14 · Cited by 4
Genetic Cardiomyopathies: An Overview of the Main Associated Pathogenic Mutations
Hama, F. M., Rocha, E. G., & Azeka, E. (2025) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20240052i · Cited by 4
Danon disease: From genetic origins and molecular defects to therapeutic advances
Chaudhary, R., & Singh, A. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.102015 · Cited by 4
Danon disease in a Sardinian family: different aspects of the same mutation—a case report
Pasqualucci, D., Maiani, S., Perra, F., Cau, M., Coiana, A., Bianco, P., Olivotto, I., & Corda, M. (2023) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytad237 · Cited by 4
“in 1981, DD is an inherited dominant X-linked condition due to mutations in the lysosome-associated membrane protein 2 (LAMP-2) gene.(3) Originally postulated to be a glycogen storage defect, DD has recently been shown to be due to primary deficiency of LAMP-2 leading to impaired autophagosome/ lysosome function, resu…”
BackgroundA novel frameshift variant in LAMP2 gene mimicking choroideremia carrier retinopathy
Narayan, A. R., Taylor, L. J., Sperring, S., Shanks, M. E., Clouston, P., MacLaren, R. E., & Cehajic‐Kapetanovic, J. (2024) · Ophthalmic Genetics · doi:10.1080/13816810.2024.2404148 · Cited by 4
“Although first described in 1940 when glycogenesis of the heart led to fatal heart failure in two boys, it was only in 1981 that the signs and symptoms associated with Danon disease were characterized in two male members of a family (14,15).”
Yu, K., Guo, R., Huang, D., Yang, X., Wang, D., Huang, K., & Liang, J. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742656 · Cited by 4
Cystoid macular edema in a patient with Danon disease
Mack, H. G. (2014) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.109524 · Cited by 4
“[2,3] Cardiac disease in males is usually severe.”
Recommendations and guidance on the diagnosis and management of Danon disease
Hong, K. N., Brambatti, M., John, S., Bui, Q. M., Rigolli, M., Taylor, M. R. G., & ADLER, E. D. (2021) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2021.1882994 · Cited by 4
“(A, B, and C) generated by alternative splicing [11].”
BackgroundChen, X., Fu, L., He, J., Bai, R., Zeng, S., Liao, H., Deng, H., Xue, Y., Wu, S., & Liu, Y. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0572 · Cited by 4
Focus on Paediatric Restrictive Cardiomyopathy: Frequently Asked Questions
Zampieri, M., Filippo, C. D., Zocchi, C., Fico, V., Golinelli, C., Spaziani, G., Calabri, G. B., Bennati, E., Girolami, F., Marchi, A., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13243666 · Cited by 4
“Danon disease is a rare X-linked–dominant storage disease due to mutations in the LAMP2 gene affecting lysosomal degradation of glycogen [52,53].”
BackgroundPlekhm2 acts as an autophagy modulator in murine heart and cardiofibroblasts
Etzion, S., Hijaze, R., Segal, L., Pilcha, S., Masil, D., Levi, O., Elyagon, S., Levitas, A., Etzion, Y., & Parvari, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-65670-5 · Cited by 4
“Lysosome-associated membrane protein 2 (LAMP2)- deficient mice also exhibit excessive accumulation of autophagic vacuoles and impaired autophagic degradation of long-lived proteins, resulting in cardiomyopathy 36,37 .”
Xuan, L., Chen, J., Yang, H., Hao, J., Li, S., Zhang, Q., Zhang, H., Wang, S., Luo, H., Guo, J., et al. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02511-y · Cited by 4
“It has been demonstrated that LAMP2 deficiency results in Danon disease clinical features with familial hypertrophic cardiomyopathy [10]; moreover, it is known that LAMP2 is absolutely necessary for the fussion of autophagosomes with lysosomes [11].”
Histological and Histochemical Changes
(2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-7471-4.00004-5 · Cited by 4
Perlmutter, D. H. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.025 · Cited by 4
Identification of a Novel Splicing-Altering LAMP2 Variant in a Chinese Family with Danon Disease
Fu, D., Wang, S., Luo, Y., Wu, S., & Peng, D. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14417 · Cited by 4
Danon Disease in a 14-Year-Old
Guerra, E. C., Beutelspacher-Fernandez, K., Silva-Estrada, J. A., Santa-Ana-Bayona, M. J., Martinez‐Dominguez, P., Agredano-Chavez, C. P., Pardiño-Vega, M. A., Yanez‐Felix, A. L., Yokoyama-Rebollar, E., & Espinola-Zavaleta, N. G. (2024) · JACC Case Reports · doi:10.1016/j.jaccas.2024.102603 · Cited by 4
Cho, A., & Noguchi, S. (2013) · InTech eBooks · doi:10.5772/55223 · Cited by 4
“The former is caused by a deficiency of lysosomal enzymes within the vacuoles, whereas the latter is caused by a deficiency of lysosomal membrane structural protein [9].”
BackgroundInfluentialRodzaje śmierci komórki The types of cell death
Izdebska, M., & Grzanka, A. (2007) · Cited by 4
Mild form of Danon disease: two case reports
Yasui, T., Nagaoka, U., Oya, Y., Uruha, A., Karashima, J., Funai, A., Miyamoto, K., Matsubara, S., Sugaya, K., Takahashi, K., et al. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.07.017 · Cited by 4
Self-citationGenetic Abnormalities of the Sinoatrial Node and Atrioventricular Conduction
Porta‐Sánchez, A., & Priori, S. G. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2021.06.005 · Cited by 4
Paranal, R. M., Teekakirikul, P., Ho, C. Y., Fatkin, D., & Seidman, C. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812532-8.00002-1 · Cited by 4
Autophagy, the “Master” Regulator of Cellular Quality Control: What Happens when Autophagy Fails?
Raquel, A., Catarina, R. A., & Morais, S. (2013) · InTech eBooks · doi:10.5772/55196 · Cited by 4
Nishino, I. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)86010-6 · Cited by 4
“The LAMP-2 gene is located on Xq24, while the gene for LAMP-1 is on 13q34.”
BackgroundSelf-citationKarpati, G., & Sinnreich, M. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1203 · Cited by 4
“lamp-2 deficiency [54], alpha glucosidase deficiency [55], and x-linked myopathy with excessive autophagy [56]) and nonlysosomal disorders (e.”
BackgroundFischer, D., Paus, S., & Schröder, R. (2003) · Der Nervenarzt · doi:10.1007/s00115-003-1575-5 · Cited by 4
Colombo, M., & Símon, H. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0021581 · Cited by 7
Chloroquine and hydroxychloroquine induced cardiomyopathy: A systematic review of literature
Neto, V. D., Fiuza, J. G., Pires, I., dos Santos, L. F., & Costa, A. (2025) · REC CardioClinics · doi:10.1016/j.rccl.2025.01.011 · Cited by 3
Altered Splicing of LAMP2 in a Multigenerational Family from Latvia Affected by Danon Disease
Stavusis, J., Mičule, I., Grīnfelde, I., Zdanovica, A., Pudulis, J., Valeiņa, S., Sepetiene, S., Lāce, B., & Inashkina, I. (2024) · Medicina · doi:10.3390/medicina60010099 · Cited by 3
“The functional phenotypes of patients with Danon disease have been associated with heterozygous and hemizygous variants in the LAMP2 gene [7,10–12].”
BackgroundSavy, C., Bourgoin, M., Cluzeau, T., Jacquel, A., Robert, G., & Auberger, P. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00691-0 · Cited by 3
Electron Microscopic Findings in Skin Biopsies from Patients with Danon Disease
Alroy, J., Pfannl, R., Slavov, D. B., & Taylor, M. R. G. (2010) · Ultrastructural Pathology · doi:10.3109/01913123.2010.499024 · Cited by 3
Prise en charge des maladies héréditaires du métabolisme à l’âge adulte
Maillot, F., Lavigne, C., & Douillard, C. (2012) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(12)51271-0 · Cited by 3
Loktionov, A., Kobzeva, K., Dorofeeva, A., Babkina, M., Kolodezhnaya, E., & Bushueva, O. Y. (2024) · Journal of Molecular Pathology · doi:10.3390/jmp5030026 · Cited by 3
“Autophagy is essential for preventing atherosclerosis [43,44] and VEGFR1 is vital for angiogenesis and vascular permeability, acting as a decoy to sequester VEGF and prevent intracellular signaling initiation (Figure 6). maintaining cardiac cellular homeostasis [45,46].”
Eludication of pathomechanism of and development of therapy for autophagic vacuolar myopathies
Nishino, I. (2010) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.50.1 · Cited by 3
Self-citationProtein Degradation in Cardiomyocytes: Target Proteins and Clinical Consequences
Drews, O. (2016) · Springer eBooks · doi:10.1007/978-3-319-31251-4_7 · Cited by 3
Splicing mutation in LAMP2 gene leading to exon skipping and cardiomyopathy development
Sivitskaya, L. N., Vaikhanskaya, T. G., Даниленко, Н. Г., Siniauskaya, M. G., Liaudanski, A. D., Kurushka, T. V., Yermakovich, D., & Davydenko, O. G. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100564 · Cited by 3
Clinical and molecular characterization of seven patients with Danon disease
Wang, X.-Y., Wang, B., Zhu, X., Ma, Z., Liu, Y., Lei, C., Yang, Q., Hu, D., Zhao, X., Liu, Z.-R., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9826 · Cited by 3
“In 2000, Nishino et al (2) concluded that a primary deficiency of lysosome‑associated membrane protein‑2 (LAMP2) led to Danon disease.”
BackgroundDisorders of Carbohydrate Metabolism
Kishnani, P. S., & Chen, Y.-T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00004-2 · Cited by 3
The Genetics of Conduction Disease
Beinart, R., Ruskin, J. N., & Milan, D. J. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.11.006 · Cited by 3
Larner, J. A. (2013) · Cited by 3
Sewry, C. A., Jimenez-Mallebrera, C., Brown, S., & Muntoni, F. (2008) · CRC Press eBooks · doi:10.1201/b13319-23 · Cited by 3
Histological and Histochemical changes
(2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-4340-6.00004-5 · Cited by 3
Ultrastructural study of muscle
Oldfors, A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.010 · Cited by 3
Defects in transmembrane proteins
Ioannou, Y. A. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0009 · Cited by 3
Molecular Pathways in Cardiomyopathies
Miyamoto, S. D., Stauffer, B. L., & Sucharov, C. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800040-3.00003-0 · Cited by 3
Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders
Nelson, B., Hashem, S. I., & ADLER, E. D. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0829-y · Cited by 3
Santer, R. (2004) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-004-0952-x · Cited by 3
“Einzelne Fälle mit ähnlicher Histologie (im Sinne einer vakuolären Glykogenspeicherung), aber mit normaler αGlukosidase-Aktivität sind beschrieben worden (Glykogenose Typ IIb, „Danon disease“), und bei einem Teil dieser Fälle konnte vor kurzem ein Defekt eines Lysosomen-assoziierten Membranproteins (LAMP2) nachgewiese…”
Molecular pathogenesis of Salla disease
Aula, N. (2003) · Helda - University of Helsinki Institutional Repository · Cited by 3
Yang, Y., Zeng, W.-H., Peng, Y., Zuo, S.-Y., Fu, Y., Xiao, Y.-M., Huang, W.-L., Wen, Z., Hu, W., Yang, Y.-Y., et al. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1386413 · Cited by 2
Chen, L., Fang, M.-J., Xu, D., Shi, Y.-G., Yong-zhu, H., Yu, X., & Xu, Y. (2024) · Journal of Neuromuscular Diseases · doi:10.1177/22143602241305510 · Cited by 2
Targeting TMEM175 in Lysosomal Physiology and Human Diseases
Lu, G., Fan, S., Gu, J., Zhou, W., Zhang, X., Fang, G., & Cao, Z. (2025) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x385236250729200924 · Cited by 2
Pseudo–Pre-Excitation Unraveled Down to Its Core
Ng, A. K., Ng, K.-M., Tse, H., Lai, W., Chan, W. S., Siu, C., & Fan, K. (2014) · Circulation · doi:10.1161/circulationaha.114.008601 · Cited by 2
Gill, I., Kim, J. H., Moon, J., Kim, Y. J., & Kim, N. S. (2018) · Journal of genetic medicine · doi:10.5734/jgm.2018.15.2.87 · Cited by 2
Refining the Role of Autophagy in Hypertrophic Cardiomyopathy
Ren, J. T. (2018) · International Journal of Cell Science & Molecular Biology · doi:10.19080/ijcsmb.2018.04.555637 · Cited by 2
Mahendran, G., & Schwarz, M. A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.109098 · Cited by 2
Clinical manifestations and MRI features of Danon disease: a case series
Zhang, Y., Zhao, R., Yuan, Y., Yu, Y., Liu, B., & Li, X. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03356-y · Cited by 2
“Currently, detection of mutations in the lysosomal-associated membrane protein-2 (LAMP-2) gene is the gold standard for DD diagnosis [2], and endocardial biopsy is also a critical method for diagnosing it.”
Дергилев, К. В., Goltseva, Y., Цоколаева, З. И., Beloglazova, I. B., Yarushkina, I. S., Azimova, E., Ratner, E. I., & Parfenova, E. V. (2025) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin20252001113 · Cited by 2
Myopathy and peripheral neuropathy associated with the 3243A>G mutation in mitochondrial DNA
Kärppä, M. (2004) · Cited by 2
Lorts, A., Ryan, T. D., & Jefferies, J. L. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6356-5_29 · Cited by 2
Chapter 31 Metabolic myopathies
Gooch, C. L., & DiMauro, S. (2003) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(09)70141-8 · Cited by 2
Self-citationRole of HspB1 and HspB8 in Hereditary Peripheral Neuropathies: Beyond the Chaperone Function
Carra, S., & Landry, J. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8231-3_7 · Cited by 2
Anesthetic implications of Danon disease
August, D. A. (2009) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2009.03125.x · Cited by 2
Enfermedad de Danon y nueva mutación del gen LAMP-2 en una familia española
Modrego, P. J., Pisón, J. L., & Alfaro, J. (2015) · Neurología · doi:10.1016/j.nrl.2015.07.003 · Cited by 2
Lysosome Dysfunction: An Emerging Mechanism of Xenobiotic‐Induced Toxicity
Lu, S., Jessen, B. A., Will, Y., & Stevens, G. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch19 · Cited by 2
Cardio-Skeletal Muscle Disease Associated With Syndromes
Khuchua, Z. A., & Towbin, J. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800040-3.00015-7 · Cited by 2
Nonmitochondrial Metabolic Cardioskeletal Myopathies
El‐Gharbawy, A., & Vockley, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800040-3.00014-5 · Cited by 2
Pathophysiology of Cardiomyopathies
Towbin, J. A., Jefferies, J. L., & Ryan, T. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00154-2 · Cited by 2
Autophagic Regulation of Cardiomyocyte Survival and Heart Regeneration
Aki, T., Noritake, K., Unuma, K., & Uemura, K. (2018) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-98146-8_7 · Cited by 2
Axelsson, A., & Ho, C. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800040-3.00006-6 · Cited by 2
Zhu, X., Wang, J., Chong, H., Wang, J., & Wang, D. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101994 · Cited by 2
Early diagnosis of infantile Danon disease complicated by tetralogy of Fallot
Shimozono, T., Ueno, K., Shiokawa, N., Ohno, S., & Kawano, Y. (2021) · Pediatrics International · doi:10.1111/ped.14542 · Cited by 2
DiMauro, S., Akman, H. O., & Paradas, C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_63 · Cited by 2
Self-citationAutophagy and Huntington's disease
Croce, K. R., Jasutkar, H. G., & Yamamoto, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00018-2 · Cited by 2
Self-citationDescription of muscle disease – specific diseases
Karpati, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.014 · Cited by 2
Luiro, K. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 2
Food for thought: autophagic vacuolar myopathies
Strehle, E. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.155010 · Cited by 2
“Further studies revealed that Danon disease (OMIM 300257) is caused by mutations in the LAMP2 gene on Xq24 which encodes the lysosome-associated membrane proteins 2a, 2b and 2c.(16) They have multiple functions which are not fully understood.”
BackgroundCalcified mediastinal haematoma: a rare case of cardiac constriction
Leslie, S. J., Brackenbury, E., & Spratt, J. (2004) · Heart · doi:10.1136/hrt.2003.029090 · Cited by 2
“To test this hypothesis further, we analysed the possible involvement of Danon’s disease in consecutive index cases of idiopathic HCM. Danon’s disease is an X linked (dominant rather than recessive) lysosomal disease due to a primary deficiency of lysosome associated membrane protein 2 (LAMP2).”
BackgroundHanna, R. A. (2011) · eScholarship (California Digital Library) · Cited by 2
X-linked myopathy with excessive autophagy
INSERM (2020) · Definitions · doi:10.32388/aiz8b0 · Cited by 2
Examining Autophagy and Mitophagy as Inducible Mechanisms of Cellular Remodelling
Bloemberg, D. (2017) · UWSpace (University of Waterloo) · Cited by 3
Novel CLN3 mutation causing autophagic vacuolar myopathy
Taschner, P. E. M., Cortese, A., & Tucci, A. (2015) · Neurology · doi:10.1212/wnl.0000000000001248 · Cited by 2
Programmable Hybridization Assemble Nicked Displacement Amplification for Detecting Ricin ToxinPreprint
Wang, Y., Peng, Y., Bai, J., Li, S., Han, D., Ren, S., Qin, K., Li, S., Zhou, H., & Gao, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-917396/v1 · Cited by 2
Autophagy in Cancer Progression and Therapeutics
Kantserova, K., & Ulasov, I. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097973 · Cited by 2
“Investigations into the role of autophagy in the heart have shown that a lack of the protein necessary for autolysosome formation (lysosome-associated membrane protein 2) leads to accumulation of autophagic vacuoles, dysregulation of protein degradation, and the development of cardiomyopathy [7,8].”
BackgroundShedding new light on vasculitis: how the LAMP story unfolded
Rothe, H. M. (2012) · Journal of Nephrology · doi:10.5301/jn.5000107 · Cited by 1
Lu, J., Qi, Y., Chen, M., Wang, C., Yin, J., & Yang, S. (2025) · Cardiology in the Young · doi:10.1017/s1047951125101546 · Cited by 1
“5,11,12 The three LAMP2 isoforms, especially LAMP-2B , play a key role in lysosomal autophagy.”
Takehara, T., Kido, T., Taira, M., Watanabe, T., Narita, J., Ishida, H., Ishii, R., Ueno, T., & Miyagawa, S. (2025) · Journal of Artificial Organs · doi:10.1007/s10047-025-01534-7 · Cited by 1
“Although no abnormal - ities in glycolytic enzyme activity were detected, Nishino et al. [10 ] found primary LAMP-2 deficiency in patients with Danon disease, which was recognized as the cause of the disease.”
Ribeiro, G. N. P., Lipari, L. F. V. P., Senra, P. M., Pires, L. V. L., Mizuta, M. H., Olivetti, N., Aiello, V. D., & Krieger, J. E. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250186 · Cited by 1
Proteostasis and ageing dissidence
Babu, N. L., Whalen, K. M., & Freeman, B. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2025.0266 · Cited by 1
Autophagy in the Cardiovascular System
Nishida, K., Yamaguchi, O., & Otsu, K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385101-7.00003-6 · Cited by 1
Autophagy in Cardiac Physiology and Disease
Hill, J. A., Lavandero, S., & Rothermel, B. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00030-2 · Cited by 1
Danon disease: A case report and literature overview
Catovic, S., & Otašević, P. (2007) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0704197c · Cited by 1
CASE REPORT: Early‐onset lysosomal glycogen storage disease with normal acid maltase
Dayan, R. M., & Renaud, D. L. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1010585714729 · Cited by 1
Lymphoma in Danon disease with chronic rhabdomyolysis treated with EPOCH-R: A case report
Porpaczy, E. A., Mayerhoefer, M. E., Salzer‐Muhar, U. E., & Jaeger, U. (2016) · Medicine · doi:10.1097/md.0000000000004237 · Cited by 1
“Therefore, the patient was treated with the EPOCH-R protocol, which includes continuous administration of doxorubicin over 4 days, instead of R-CHOP, in which the anthracycline is given in a short single infusion.”
MethodCardiac Autophagy and Its Regulation by Reversible Protein Acetylation
Xie, M., & Hill, J. A. (2016) · Cardiac and vascular biology · doi:10.1007/978-3-319-41457-7_10 · Cited by 1
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.